Benlysta 120 TR


Benlysta is explicitly demonstrated to treat lupus. This drug initiates a human monoclonal immune response that is coordinated against the human BLyS protein.

Quantity Discount (%) Price
1 - 5 $359.00
6 - 10 2.79 % $349.00
11 - 20 4.18 % $344.00
21+ 5.57 % $339.00
SKU: 88877 Category:


Benlysta is an FDA-approved drug that is specifically indicated to treat and manage the symptoms of lupus. This substance is a human monoclonal antibody that is directed against the human BLyS protein so as to affect the survivability of B-cells, which are immune cells that are involved in the production of autoantibodies. Benlysta inhibits the binding of B Lymphocyte Stimulator (BLyS), a protein essential for B-cell survival, to its receptor on B-cells. By doing so, the numbers of B-cell numbers decline, and related disease activity is subsequently lowered.